Kelli Scott1,2, Sara J Becker1,2, Sarah A Helseth1, Ian J Saldanha3,4, Ethan M Balk3, Gaelen P Adam3, Kristin J Konnyu3, Dale W Steele3,5. 1. Department of Behavioral and Social Sciences, Brown University School of Public Health, Providence, RI, USA. 2. Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, RI, USA. 3. Department of Health Services, Policy, and Practice, Brown University School of Public Health, Providence, RI, USA. 4. Department of Epidemiology, Brown University School of Public Health, Providence, RI, USA. 5. Department of Emergency Medicine, Alpert Medical School of Brown University, Providence, RI, USA.
Abstract
BACKGROUND: Co-occurring mental health and substance use (SU) disorders among adolescents are common, with two-thirds of adolescents who seek SU treatment also requiring support for mental health. Primary care physicians play a key role in the pharmacological treatment of mental health disorders among adolescents, however, little is known about the impact of these treatments on SU outcomes. OBJECTIVES: This systematic review summarizes the evidence regarding commonly used pharmacotherapy interventions for mental health and their impact on adolescent SU. METHODS: Literature searches were conducted across five databases as part of a larger systematic review of adolescent SU interventions. Studies were screened for eligibility by two researchers, and study data were extracted regarding study design, patient and treatment characteristics and results. Risk of bias analyses and qualitative syntheses were completed to evaluate the strength of the evidence and the impact of pharmacotherapy on SU outcomes. RESULTS: Ten randomized controlled trials exploring seven pharmacotherapies met criteria for inclusion. All studies had low to moderate risk of bias. Four studies evaluated pharmacotherapy for co-occurring depression and SU, three evaluated attention deficit hyperactivity disorder and SU, and three evaluated bipolar disorder and SU. Five of the 10 studies also included a behavioural intervention. We found no evidence that pharmacotherapy for co-occurring mental health diagnoses impacted SU. CONCLUSION: Family medicine clinicians prescribing pharmacotherapy for mental health should be aware that additional interventions will likely be needed to address co-occurring SU.
BACKGROUND: Co-occurring mental health and substance use (SU) disorders among adolescents are common, with two-thirds of adolescents who seek SU treatment also requiring support for mental health. Primary care physicians play a key role in the pharmacological treatment of mental health disorders among adolescents, however, little is known about the impact of these treatments on SU outcomes. OBJECTIVES: This systematic review summarizes the evidence regarding commonly used pharmacotherapy interventions for mental health and their impact on adolescent SU. METHODS: Literature searches were conducted across five databases as part of a larger systematic review of adolescent SU interventions. Studies were screened for eligibility by two researchers, and study data were extracted regarding study design, patient and treatment characteristics and results. Risk of bias analyses and qualitative syntheses were completed to evaluate the strength of the evidence and the impact of pharmacotherapy on SU outcomes. RESULTS: Ten randomized controlled trials exploring seven pharmacotherapies met criteria for inclusion. All studies had low to moderate risk of bias. Four studies evaluated pharmacotherapy for co-occurring depression and SU, three evaluated attention deficit hyperactivity disorder and SU, and three evaluated bipolar disorder and SU. Five of the 10 studies also included a behavioural intervention. We found no evidence that pharmacotherapy for co-occurring mental health diagnoses impacted SU. CONCLUSION: Family medicine clinicians prescribing pharmacotherapy for mental health should be aware that additional interventions will likely be needed to address co-occurring SU.
Authors: Nancy D Berkman; Kathleen N Lohr; Mohammed T Ansari; Ethan M Balk; Robert Kane; Marian McDonagh; Sally C Morton; Meera Viswanathan; Eric B Bass; Mary Butler; Gerald Gartlehner; Lisa Hartling; Melissa McPheeters; Laura C Morgan; James Reston; Priyanka Sista; Evelyn Whitlock; Stephanie Chang Journal: J Clin Epidemiol Date: 2014-12-20 Impact factor: 6.437
Authors: Xinyu Zhou; Teng Teng; Yuqing Zhang; Cinzia Del Giovane; Toshi A Furukawa; John R Weisz; Xuemei Li; Pim Cuijpers; David Coghill; Yajie Xiang; Sarah E Hetrick; Stefan Leucht; Mengchang Qin; Jürgen Barth; Arun V Ravindran; Lining Yang; John Curry; Li Fan; Susan G Silva; Andrea Cipriani; Peng Xie Journal: Lancet Psychiatry Date: 2020-07 Impact factor: 27.083
Authors: Andrea Cipriani; Xinyu Zhou; Cinzia Del Giovane; Sarah E Hetrick; Bin Qin; Craig Whittington; David Coghill; Yuqing Zhang; Philip Hazell; Stefan Leucht; Pim Cuijpers; Juncai Pu; David Cohen; Arun V Ravindran; Yiyun Liu; Kurt D Michael; Lining Yang; Lanxiang Liu; Peng Xie Journal: Lancet Date: 2016-06-08 Impact factor: 79.321
Authors: Robert L Findling; Maria E Pagano; Nora K McNamara; Robert J Stansbrey; Jon E Faber; Jacqui Lingler; Christine A Demeter; Denise Bedoya; Michael D Reed Journal: Child Adolesc Psychiatry Ment Health Date: 2009-03-19 Impact factor: 3.033